• eye on a chip
  • eye chip

Unmet Clinical Need

Dry eye disease (DED) is a common disease with shockingly few FDA-approved drug options, partially because of the difficulties of modeling the complex pathophysiology in human eyes. There is a significant need for new and reliable techniques for assessing ocular complications. These techniques could also lead to innovative approaches towards drug delivery and the real-time monitoring of ocular health.

Proposed Healthcare Solution

Blinking, in-vitro model of the human ocular surface that can be used as an organ stand-in to study eye diseases and drug treatment testing

Development Stage

Proof of Concept

Funding Cycle



Dan Huh, PhD
Vatinee Y. Bunya, MD, MSCE


For more information on this technology, please contact Penn Center for Innovation at pciinfo@pci.upenn.edu